Ms. Jeanne M Keahon, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 27 Church St, Treadwell, NY 13846 Phone: 607-829-8329 |
News Archive
A new study published in the September issue of Journal of Vascular Surgery reveals that rural and urban patients have equivalent access to endovascular aneurysm repair (EVAR) care from vascular surgeons, increased referral to high-volume hospitals and improved outcomes after repair.
Up to 15 percent of patients who take cholesterol-lowering statin medications experience muscle pain or other side effects, and many patients simply stop taking the drugs.
In an ideal world, the newest and most effective drugs for chronic inflammatory conditions would immediately help everyone who took them.
A new study reveals that a drug that was taken by millions of pregnant women decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems. The study shows that many of these daughters are now over 40 and may not even know of their risk if their mothers never realized or told them they had used the drug, a synthetic estrogen called DES or Diethyl stilbesterol.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Japanese Patent Office has granted claims in a second patent application (JP Application Number 2006-317758) for the Tuschl II patent series, entitled "RNA Interference Mediating Small RNA Molecules." In May 2008, the Japanese Patent Office granted a related set of claims in the Tuschl II patent series (JP 4 095 895).
› Verified 9 days ago